Technology area: Medical Devices & Mechanical Engineering
18 pending office actions • 11 clients • 15 examiners • 8 art units • 0 of 18 (0%) have an AI response strategy ready
Veros Legal Solutions, LLP has 17 pending office actions in Medical Devices & Mechanical Engineering and 282 career applications. The application figure provides context for the active docket and indicates reported prosecution activity beyond the matters currently pending.
Its resolved allowance rate is 75.93%, with an average of 3.11 office actions per allowance. These measures give practitioners a basis for assessing resolved outcomes and the examination activity associated with allowance.
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (17%) |
| §102 only | 1 (6%) |
| §112 only | 1 (6%) |
| Double-patenting only | 1 (6%) |
| Multi-statute (no §101) | 12 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GEIGER, RACHAEL L | 3 | 82.3% | +18.3% |
| ALLEN, ROBERT F | 2 | 72.9% | +62.6% |
| FISHBACK, ASHLEY LAUREN | 1 | 80.0% | +22.1% |
| HALL, FORREST G | 1 | 60.2% | +31.8% |
| GOMES, SRISTI DIVINA | 1 | 25.0% | -33.3% |
| MARCETICH, ADAM M | 1 | 72.8% | +18.8% |
| STRACHAN, KATE ELIZABETH | 1 | 49.6% | +31.5% |
| CIRULNICK, EMILY NICOLE | 1 | 40.0% | +0.0% |
| HUH, VYNN V | 1 | 61.9% | +44.4% |
| LEVY, BRANDON WILLIAM | 1 | 62.9% | +46.5% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19572852 | INTRAVASCULAR FLOW DIVERTER AND RELATED METHODS | FISHBACK, ASHLEY LAUREN | — |
| 18958576 | VASCULAR ACCESS LINE AND IMPLANTATION DEVICES AND METHODS | GEIGER, RACHAEL L | — |
| 18918674 | VASCULAR ACCESS LINE AND IMPLANTATION DEVICES AND METHODS | GEIGER, RACHAEL L | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17146253 | MINIMALLY INVASIVE PORT IMPLANTATION | ALLEN, ROBERT F | 31d overdue |
| 17625637 | TOGGLING VASCULAR ACCESS PORT | MARRISON, SAMUEL JOSEPH | 22d overdue |
| 18032030 | VASCULAR ACCESS KIT | MELHUS, BENJAMIN S | 53d |
| 18373829 | SYSTEM AND METHODS TO ENHANCE CHEMOTHERAPY DELIVERY AND REDUCE TOXICITY | LEVY, BRANDON WILLIAM | 61d |
| 19477303 | MONITORING SYSTEM FOR MEASURING VIBRATIONS | HALL, FORREST G | — |
| 19194548 | VASCULAR OCCLUSION COILS AND OCCLUDERS FORMED THEREWITH | GEIGER, RACHAEL L | — |
| 19100430 | VASCULAR ACCESS WIRE TIP COMPRISING A CRANK | GOMES, SRISTI DIVINA | — |
| 18827495 | DEVICES, SYSTEMS AND METHODS FOR THE BROAD-SPECTRUM REDUCTION OF PRO-INFLAMMATORY CYTOKINES IN BLOOD | MARCETICH, ADAM M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17146253 | MINIMALLY INVASIVE PORT IMPLANTATION | ALLEN, ROBERT F | 31d overdue |
| 18373829 | SYSTEM AND METHODS TO ENHANCE CHEMOTHERAPY DELIVERY AND REDUCE TOXICITY | LEVY, BRANDON WILLIAM | 61d |
| 19572852 | INTRAVASCULAR FLOW DIVERTER AND RELATED METHODS | FISHBACK, ASHLEY LAUREN | — |
| 19477303 | MONITORING SYSTEM FOR MEASURING VIBRATIONS | HALL, FORREST G | — |
| 19194548 | VASCULAR OCCLUSION COILS AND OCCLUDERS FORMED THEREWITH | GEIGER, RACHAEL L | — |
| 18958576 | VASCULAR ACCESS LINE AND IMPLANTATION DEVICES AND METHODS | GEIGER, RACHAEL L | — |
| 18918674 | VASCULAR ACCESS LINE AND IMPLANTATION DEVICES AND METHODS | GEIGER, RACHAEL L | — |
| 18827495 | DEVICES, SYSTEMS AND METHODS FOR THE BROAD-SPECTRUM REDUCTION OF PRO-INFLAMMATORY CYTOKINES IN BLOOD | MARCETICH, ADAM M | — |
| Client (Assignee) | Pending OAs |
|---|---|
| Portal Access, Inc. | 3 |
| Venacore Inc. | 2 |
| Embrace Medical Ltd. | 2 |
| Tacc Inc. | 2 |
| Sigyn Therapeutics, Inc. | 2 |
| Apollo Medical, LLC | 2 |
| NV MEDTECH, Inc. | 1 |
| Ms2Protect AB | 1 |
| Sigyn Therapeutics | 1 |
| Luna Health | 1 |
| SpectraCure AB | 1 |
| Art Unit | Apps |
|---|---|
| 3771 | 5 |
| 3781 | 3 |
| 3783 | 3 |
| 3791 | 2 |
| 3792 | 2 |
| 3732 | 1 |
| 3741 | 1 |
| 3797 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19572852 | INTRAVASCULAR FLOW DIVERTER AND RELATED METHODS | NV Medtech, Inc. | FISHBACK, ASHLEY LAUREN | 3771 | §112 | Non-Final OA | — | Pending | Mar 19, 2026 |
| 19477303 | MONITORING SYSTEM FOR MEASURING VIBRATIONS | Ms2Protect AB | HALL, FORREST G | 3732 | §102§103 | Non-Final OA | — | Pending | Oct 21, 2025 |
| 19194548 | VASCULAR OCCLUSION COILS AND OCCLUDERS FORMED THEREWITH | Venacore Inc. | GEIGER, RACHAEL L | 3771 | §102§103 | Non-Final OA | — | Pending | Apr 30, 2025 |
| 19100430 | VASCULAR ACCESS WIRE TIP COMPRISING A CRANK | Embrace Medical Ltd. | GOMES, SRISTI DIVINA | 3791 | §102§112 | Non-Final OA | — | Pending | Jan 31, 2025 |
| 18958576 | VASCULAR ACCESS LINE AND IMPLANTATION DEVICES AND METHODS | Tacc Inc. | GEIGER, RACHAEL L | 3771 | §102 | Non-Final OA | — | Pending | Nov 25, 2024 |
| 18918674 | VASCULAR ACCESS LINE AND IMPLANTATION DEVICES AND METHODS | Tacc Inc. | GEIGER, RACHAEL L | 3771 | §103 | Final Rejection | — | Pending | Oct 17, 2024 |
| 18827495 | DEVICES, SYSTEMS AND METHODS FOR THE BROAD-SPECTRUM REDUCTION OF PRO-INFLAMMATORY CYTOKINES IN BLOOD | Sigyn Therapeutics, Inc. | MARCETICH, ADAM M | 3781 | §103§112 | Non-Final OA | — | Pending | Sep 06, 2024 |
| 18802722 | EXTRA-LUMEN ADSORPTION OF VIRAL PATHOGENS FROM BLOOD | Sigyn Therapeutics, Inc. | STRACHAN, KATE ELIZABETH | 3781 | §102§103 | Non-Final OA | — | Pending | Aug 13, 2024 |
| 18763717 | SYSTEMS FOR SELECTIVE ABERRATION CORRECTION IN CORNEAL LASER ABLATION | Apollo Medical, LLC | CIRULNICK, EMILY NICOLE | 3792 | §103§112Other | Non-Final OA | — | Pending | Jul 03, 2024 |
| 18763706 | METHODS FOR SELECTIVE ABERRATION CORRECTION IN CORNEAL LASER ABLATION | Apollo Medical, LLC | HUH, VYNN V | 3792 | DP | Non-Final OA | — | Pending | Jul 03, 2024 |
| 18373829 | SYSTEM AND METHODS TO ENHANCE CHEMOTHERAPY DELIVERY AND REDUCE TOXICITY | Sigyn Therapeutics | LEVY, BRANDON WILLIAM | 3781 | §103§112 | Non-Final OA | 61d | Pending | Sep 27, 2023 |
| 18277506 | VASCULAR OCCLUDER WITH INWARDLY INSERTABLE SEGMENT | Venacore Inc. | MCEVOY, THOMAS M | 3771 | §103§112 | Final Rejection | — | Pending | Aug 16, 2023 |
| 18135417 | SYSTEMS, DEVICES AND RELATED METHODS OF CONTROLLING INSULIN MANAGEMENT FOR DELIVERING INSULIN DURING A FASTING PERIOD | Luna Health, Inc. | NGUYEN, ANDREW H | 3741 | §103 | Non-Final OA | — | Pending | Apr 17, 2023 |
| 18032030 | VASCULAR ACCESS KIT | Embrace Medical Ltd. | MELHUS, BENJAMIN S | 3791 | §102§103 | Non-Final OA | 53d | Pending | Apr 14, 2023 |
| 18014918 | SUBCUTANEOUS PORT FOR MINIMALLY INVASIVE IMPLANTATION | Portal Access, Inc. | ALLEN, ROBERT F | 3783 | §103§112 | Final Rejection | — | Pending | Jan 06, 2023 |
| 17928367 | System and Method for Distributing Radiation for Diagnostics | Spectracure AB | POPESCU, GABRIEL VICTOR | 3797 | §103 | Final Rejection | 3d overdue | Pending | Nov 29, 2022 |
| 17625637 | TOGGLING VASCULAR ACCESS PORT | Portal Access, Inc. | MARRISON, SAMUEL JOSEPH | 3783 | §102§103 | Final Rejection | 22d overdue | Pending | Jan 07, 2022 |
| 17146253 | MINIMALLY INVASIVE PORT IMPLANTATION | Portal Access, Inc. | ALLEN, ROBERT F | 3783 | §102§103§112 | Final Rejection | 31d overdue | Pending | Jan 11, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial75.9% of resolved applications prosecuted by Veros Legal Solutions, LLP were allowed, across 282 applications in USPTO records.
3.11 office actions per allowed application on average.
18 pending office actions as of October 2026, for 11 clients, before 15 examiners in 8 art units.
